1. Home /
    2. Altai Protocol Library /
  2. New Indication: Axitinib for unresectable recurrent or metastatic head and neck cancer

Altai Protocol Library

1041 protocols and counting

All protocols with references and links

All protocols reviewed by a Medical Oncologist/Hematologist

All protocols in major guidelines included

Ability to create your own protocols

Kütüphanede Ara Ara
Altai Protocol Library

New Indication: Axitinib for unresectable recurrent or metastatic head and neck cancer

New Indication: Axitinib for unresectable recurrent or metastatic head and neck cancer
Study:
  • Single-arm phase 2 trial
  • Unresectable recurrent or metastatic (R/M) head and neck squamous cell carcinoma (n=29)
  • 61% had at least 1 previous systemic treatment
Efficacy:
  • Median OS: 9.8 mos. 6-month OS: 70%
  • ORR: 42% => ORR higher in those with PI3K pathway alterations (75% vs. 17%)

Cancer. Online first 2020 Oct 20.

Swiecicki PL, et al. Efficacy of axitinib in metastatic head and neck cancer with novel radiographic response criteria.

https://doi.org/10.1002/cncr.33226

Altai Chemo Planner

Quickly Prepare Accurate Chemotherapy Orders

Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.

Learn More